Clinicopathological features of familial Alzheimer's disease associated with the M139V mutation in the presenilin 1 gene. Pedigree but not mutation specific age at onset provides evidence for a further genetic factor - PubMed (original) (raw)
Case Reports
. 1997 Mar:120 ( Pt 3):491-501.
doi: 10.1093/brain/120.3.491.
Affiliations
- PMID: 9126060
- DOI: 10.1093/brain/120.3.491
Case Reports
Clinicopathological features of familial Alzheimer's disease associated with the M139V mutation in the presenilin 1 gene. Pedigree but not mutation specific age at onset provides evidence for a further genetic factor
N C Fox et al. Brain. 1997 Mar.
Abstract
Sixteen affected individuals are described from two families with early onset autosomal dominant familial Alzheimer's disease. A mutation at codon 139 in the presenilin 1 gene on chromosome 14 results in a methionine to valine substitution which cosegregates with the disease in these families. Onset of dementia was before the age of 50 years in all individuals. The ages at onset within each family were tightly clustered but were significantly different between the families; this difference could not be accounted for by apolipoprotein E status and suggests the existence of a further genetic factor that modifies age at disease onset. The pattern of cognitive decline was similar in both families: early memory loss (initially selective for verbal memory in some individuals) was followed soon after by loss of arithmetic skills while naming and object perception skills were relatively preserved. A speech production deficit was observed in three members of one family but not in the other. Seizures were common and usually predated by myoclonic jerks by a number of years. Serial MRIs showed progressive cortical atrophy with periventricular white matter change appearing 3-4 years into the disease. PET revealed parieto-temporal hypometabolism in all individuals scanned. The diagnosis of Alzheimer's disease was confirmed with typical histopathology in one individual from each family.
Similar articles
- Alzheimer's disease due to an intronic presenilin-1 (PSEN1 intron 4) mutation: A clinicopathological study.
Janssen JC, Hall M, Fox NC, Harvey RJ, Beck J, Dickinson A, Campbell T, Collinge J, Lantos PL, Cipolotti L, Stevens JM, Rossor MN. Janssen JC, et al. Brain. 2000 May;123 ( Pt 5):894-907. doi: 10.1093/brain/123.5.894. Brain. 2000. PMID: 10775535 - Chromosome 14 linked familial Alzheimer's disease. A clinico-pathological study of a single pedigree.
Kennedy AM, Newman SK, Frackowiak RS, Cunningham VJ, Roques P, Stevens J, Neary D, Bruton CJ, Warrington EK, Rossor MN. Kennedy AM, et al. Brain. 1995 Feb;118 ( Pt 1):185-205. doi: 10.1093/brain/118.1.185. Brain. 1995. PMID: 7895004 - Chromosome 14 familial Alzheimer's disease: the clinical and neuropathological characteristics of a family with a leucine-->serine (L250S) substitution at codon 250 of the presenilin 1 gene.
Harvey RJ, Ellison D, Hardy J, Hutton M, Roques PK, Collinge J, Fox NC, Rossor MN. Harvey RJ, et al. J Neurol Neurosurg Psychiatry. 1998 Jan;64(1):44-9. doi: 10.1136/jnnp.64.1.44. J Neurol Neurosurg Psychiatry. 1998. PMID: 9436726 Free PMC article. - Phenotypic profile of early-onset familial Alzheimer's disease caused by presenilin-1 E280A mutation.
Sepulveda-Falla D, Glatzel M, Lopera F. Sepulveda-Falla D, et al. J Alzheimers Dis. 2012;32(1):1-12. doi: 10.3233/JAD-2012-120907. J Alzheimers Dis. 2012. PMID: 22766738 Review. - Three-year follow-up of a patient with early-onset Alzheimer's disease with presenilin-2 N141I mutation - case report and review of the literature.
Nikisch G, Hertel A, Kiessling B, Wagner T, Krasz D, Hofmann E, Wiedemann G. Nikisch G, et al. Eur J Med Res. 2008 Dec 3;13(12):579-84. Eur J Med Res. 2008. PMID: 19073399 Review.
Cited by
- Unraveling Molecular and Genetic Insights into Neurodegenerative Diseases: Advances in Understanding Alzheimer's, Parkinson's, and Huntington's Diseases and Amyotrophic Lateral Sclerosis.
Ciurea AV, Mohan AG, Covache-Busuioc RA, Costin HP, Glavan LA, Corlatescu AD, Saceleanu VM. Ciurea AV, et al. Int J Mol Sci. 2023 Jun 28;24(13):10809. doi: 10.3390/ijms241310809. Int J Mol Sci. 2023. PMID: 37445986 Free PMC article. Review. - Genetic testing in dementia - utility and clinical strategies.
Koriath CAM, Kenny J, Ryan NS, Rohrer JD, Schott JM, Houlden H, Fox NC, Tabrizi SJ, Mead S. Koriath CAM, et al. Nat Rev Neurol. 2021 Jan;17(1):23-36. doi: 10.1038/s41582-020-00416-1. Epub 2020 Nov 9. Nat Rev Neurol. 2021. PMID: 33168964 Review. - Blood-Brain Barrier: From Physiology to Disease and Back.
Sweeney MD, Zhao Z, Montagne A, Nelson AR, Zlokovic BV. Sweeney MD, et al. Physiol Rev. 2019 Jan 1;99(1):21-78. doi: 10.1152/physrev.00050.2017. Physiol Rev. 2019. PMID: 30280653 Free PMC article. Review. - Aging related cognitive changes associated with Alzheimer's disease in Down syndrome.
Firth NC, Startin CM, Hithersay R, Hamburg S, Wijeratne PA, Mok KY, Hardy J, Alexander DC; LonDownS Consortium; Strydom A. Firth NC, et al. Ann Clin Transl Neurol. 2018 May 20;5(6):741-751. doi: 10.1002/acn3.571. eCollection 2018 Jun. Ann Clin Transl Neurol. 2018. PMID: 29928657 Free PMC article. - Clinical aspects and biomarkers of Alzheimer's disease in Down syndrome.
Zis P, Strydom A. Zis P, et al. Free Radic Biol Med. 2018 Jan;114:3-9. doi: 10.1016/j.freeradbiomed.2017.08.024. Epub 2017 Sep 1. Free Radic Biol Med. 2018. PMID: 28870521 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical